Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Cottini · SciRah

Researcher profile · Semantic Scholar

F. Cottini

Share profile

F. Cottini — researcher profile on SciRah

h-index: 9
Works: 76
Citations: 268

Most-cited papers

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma
Cole Petrilla, Joshua Galloway, Ruchi Kudalkar, Aya Ismael +1 more
2023Cancers23 citations Open access
Semantic Scholar
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
B. Paul, M. Liedtke, Jack Khouri, R. Rifkin +13 more
2023Future Oncology18 citations Open access
Semantic Scholar
Redefining CD56 as a biomarker and therapeutic target in Multiple Myeloma.
F. Cottini, Jose Rodriguez, Tiffany Hughes, Nidhi Sharma +6 more
2022Molecular Cancer Research18 citations Open access
Semantic Scholar
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
F. Cottini, Ying Huang, Nita Williams, N. Bumma +6 more
2021Frontiers in Oncology17 citations Open access
Semantic Scholar
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies
E. Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao +27 more
2025Journal of Hematology & Oncology15 citations Open access
Semantic Scholar
CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma
Aya Ismael, Allen J Robinette, Laila Huric, J. Schuetz +4 more
2024Leukemia15 citations Open access
Semantic Scholar
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma
Michael Ozga, Qiu-Hong Zhao, Laila Huric, Cecelia R. Miller +5 more
2023Blood Cancer Journal15 citations Open access
Semantic Scholar
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience
Jordan Nunnelee, F. Cottini, Qiu-Hong Zhao, M. Faisal +8 more
2022Cancers11 citations Open access
Semantic Scholar
TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma
L. V. Longo, Tiffany Hughes, Betina McNeil-Laidley, F. Cottini +3 more
2023Haematologica10 citations Open access
Semantic Scholar
Imaging intercellular interaction and extracellular vesicle exchange in a co-culture model of chronic lymphocytic leukemia and stromal cells by lattice light-sheet fluorescence microscopy.
Sara Elgamal, F. Colombo, F. Cottini, J. Byrd +1 more
2020Methods in Enzymology9 citations
Semantic Scholar
Racial differences as predictors of outcomes in young patients with multiple myeloma
Alicia Bao, Qiu-Hong Zhao, Elizabeth Merritt, N. Bumma +6 more
2022Blood Cancer Journal8 citations Open access
Semantic Scholar
Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma
Jordan Nunnelee, F. Cottini, Qiu-Hong Zhao, M. Faisal +9 more
2021Journal of Clinical Medicine8 citations Open access
Semantic Scholar
CD56 expression predicts response to Daratumumab-based regimens
Allen J Robinette, Laila Huric, Kameron Dona, Don M. Benson +1 more
2024Blood Cancer Journal7 citations Open access
Semantic Scholar
To be or not to be: the role of CD56 in multiple myeloma
F. Cottini, D. Benson
2023OncoTarget7 citations Open access
Semantic Scholar
Comprehensive evaluation of disease characteristics and outcomes of patients with extramedullary multiple myeloma in the modern era
Megan J. Broughton, Subodh Bhatta, Doshi Sonali, N. Bumma +6 more
2025Haematologica6 citations
Semantic Scholar
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
Zachary Braunstein, Eric M. McLaughlin, M. Ruiz, Lai-Feng Wei +18 more
2022Frontiers in Oncology6 citations Open access
Semantic Scholar
G-CSF improves safety when you start the day after autologous transplant in Multiple Myeloma
D. Sborov, Yu Kyoung Cho, F. Cottini, E. Hade +9 more
2017Leukemia and Lymphoma6 citations Open access
Semantic Scholar
G-CSF Starting Day +1 after Autologous Transplant Is Safer Than Day +5 or Day +7 in Patients with Multiple Myeloma
F. Cottini, D. Sborov, Yu Kyoung Cho, M. Lamprecht +6 more
20166 citations
Semantic Scholar
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab
Charles Pei, Z. El Boghdadly, Lisa Blackburn, Nidhi Sharma +7 more
2025Blood neoplasia5 citations Open access
Semantic Scholar
Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact
Charles Pei, Lisa Blackburn, Nidhi Sharma, N. Bumma +7 more
2024Blood5 citations
Semantic Scholar
Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes
Arti Vaishnav, A. Khan, Qiu-Hong Zhao, N. Bumma +6 more
2023Blood5 citations Open access
Semantic Scholar
Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data
J. Aljabban, Sharjeel Syed, S. Syed, Michael Rohr +9 more
2023Heliyon4 citations Open access
Semantic Scholar
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma
Nidhi Sharma, Evan Benson, Qiu-Hong Zhao, Jordan Nunnelee +9 more
2023Leukemia and Lymphoma4 citations Open access
Semantic Scholar
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020
S. Devarakonda, F. Cottini, N. Bumma, A. Khan +5 more
2020Journal of Clinical Medicine4 citations Open access
Semantic Scholar
Safety and Tolerability of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Safety Run-in Results from a Phase 2 Study
B. Paul, J. Minařík, F. Cottini, C. Gasparetto +16 more
2023Blood3 citations Open access
Semantic Scholar
Transformed Plasmablastic Lymphoma Presenting With Marked Lymphocytosis and Spontaneous Tumor Lysis Syndrome
Y. Hadjiyannis, Cecelia R. Miller, Norris I. Hollie, J. Balakrishna +1 more
2023Journal of Hematology3 citations Open access
Semantic Scholar
Functional expression of aryl hydrocarbon receptor as a potential novel therapeutic target in human multiple myeloma
Tiffany Hughes, F. Cottini, Evan C Catton, David Ciarlariello +5 more
2021Leukemia and Lymphoma3 citations Open access
Semantic Scholar
A novel APOA1 mutation in a patient with renal amyloidosis: unveiling amyloid by next-generation sequencing
F. Cottini, Cherri Bott, T. Nadasdy, S. Brodsky +1 more
2019Amyloid: Journal of Protein Folding Disorders3 citations
Semantic Scholar
Aryl Hydrocarbon Receptor (AHR) Antagonism As a Transformative, Dual-Mechanism Novel Therapy for Multiple Myeloma
Taylor Gonzalez, Evan C Catton, A. Rosko, Y. Efebera +5 more
2018Blood3 citations Open access
Semantic Scholar
Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survival
Ruchi Kudalkar, Johnathan Altom, Joshua Galloway, Vincent Manning +2 more
2026Cell Death and Disease2 citations Open access
Semantic Scholar
Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Barry Paul, J. Minařík, F. Cottini, C. Gasparetto +16 more
2025eJHaem2 citations Open access
Semantic Scholar
Real World Predictors, Timing, and Outcomes of Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
Lisa Blackburn, Anthony Mansour, Qiu-Hong Zhao, F. Cottini +8 more
2024Hemato2 citations Open access
Semantic Scholar
Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Evandro D. Bezerra, George Durisek, Qiu-Hong Zhao, N. Denlinger +17 more
2024Blood2 citations
Semantic Scholar
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
A. Khan, Filiz Yucebay, Qiu-Hong Zhao, E. Umyarova +7 more
2022Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.
A. Khan, Michael Ozga, Harshil Bhatt, Muhammad Saad Faisal +9 more
2022Clinical Lymphoma, Myeloma & Leukemia2 citations
Semantic Scholar
Targeting the Mitotic Checkpoint in Myeloma with OSU-13, a Novel Mps1/Ttk Inhibitor
Larissa Valle Guilhen Longo, Betina McNeil-Laidley, F. Cottini, Tiffany Hughes +3 more
2021Blood2 citations Open access
Semantic Scholar
Race as a predictor of outcome in young patients with myeloma.
F. Cottini, Alicia Bao, Nidhi Sharma, A. Khan +6 more
20212 citations
Semantic Scholar
Prognostic factors and outcomes in patients with hematological malignancies developing therapy-related acute myeloid leukemia.
Justin Jiang, Joshua Galloway, Andrew Srisuwananukorn, U. Borate +9 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Real-World Outcomes of Monoclonal Gammopathy of Renal Significance (MGRS) in the Era of Novel Therapies
F. Cottini, Ana Ávila-Rodriguez, K. Sweiss, C. Uzoka +6 more
2024Blood1 citations
Semantic Scholar
Evaluation of Characteristics and Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia Treated with Modern Therapies
Megan J. Broughton, Subodh Bhatta, Nidhi Sharma, E. Umyarova +6 more
2024Blood1 citations
Semantic Scholar
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
Alicia Bao, Qiu-Hong Zhao, Ruchi Kudalkar, Jose Rodriguez +8 more
2023Frontiers in Oncology1 citations Open access
Semantic Scholar
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma
A. Khan, Kiatlyn Dvorak, Qiu-Hong Zhao, N. Bumma +6 more
2023Haematologica1 citations Open access
Semantic Scholar
The Co-Occurrence of 1q21+/1q23+ and t(4;14) Abnormalities with Specific Clone Size Is Predictive of Shorter Response to Transplant in Patients with Multiple Myeloma
Michael Ozga, Qiu-Hong Zhao, N. Bumma, A. Rosko +5 more
2022Blood1 citations
Semantic Scholar
CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies
F. Cottini, Jose Rodriguez, Max Birmingham, Tiffany Hughes +6 more
2021Blood1 citations Open access
Semantic Scholar
Comparison of Patient Outcomes with Two Different Formulations of Melphalan As Conditioning Chemotherapy for Autologous Stem Cell Transplantation in Multiple Myeloma
Filiz Yucebay, Ashleigh Keiter, Qiu-Hong Zhao, A. Neal +10 more
20201 citations Open access
Semantic Scholar
Daratumumab-induced lymphopenia predicts adverse events and outcomes in patients with myeloma.
F. Cottini, Nita Williams, N. Bumma, A. Khan +5 more
20201 citations
Semantic Scholar
Characterization of Monoclonal Gammopathy of Undetermined Significance Progression to Multiple Myeloma through Meta-Analysis of GEO Data
J. Aljabban, David Chen, F. Cottini, S. Syed +6 more
2019Blood1 citations
Semantic Scholar
Moving Mountains: Improving Access to Autologous Stem Cell Transplant for Vulnerable Patient Populations
Srinivas Devarakonda, Qiu-Hong Zhao, Suzanne Keirns, N. Bumma +10 more
2026Cancers0 citations Open access
Semantic Scholar
Impact of Infusion Timing on Safety and Efficacy of Anti-CD19 and Anti-BCMA CAR T Therapies
Sidharth Iyer, T. Voorhees, N. Denlinger, A. Rosko +6 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Reshaping the definition of high-risk disease in the immune effector therapy era in multiple myeloma
Yoshito Nishimura, Gunjan Gaur, F. Cottini, S. Zanwar
2026Frontiers in Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Rosko×27
Invite
A. Rosko — researcher profile on SciRah
N. Bumma×24
Invite
N. Bumma — researcher profile on SciRah
S. Devarakonda×24
Invite
S. Devarakonda — researcher profile on SciRah
D. Benson×21
Invite
D. Benson — researcher profile on SciRah

×20

Invite

A. Khan — researcher profile on SciRah

Nidhi Sharma×19

Invite

Nidhi Sharma — researcher profile on SciRah

E. Umyarova×19

Invite

E. Umyarova — researcher profile on SciRah

Don M. Benson×15

Invite

Don M. Benson — researcher profile on SciRah

Qiu-Hong Zhao×10

Invite

Qiu-Hong Zhao — researcher profile on SciRah

Invite

Y. Efebera — researcher profile on SciRah

Tiffany Hughes×8

Invite

Tiffany Hughes — researcher profile on SciRah

Invite

M. Chaudhry — researcher profile on SciRah